Valerian
CAS 8057-49-6
Valerian (CAS 8057-49-6) is a pharmaceutical compound with 0 bioactivity targets and 134 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Drug Label Active Ingredients
Active ingredient and active moiety rows from source drug product labels.
| Product | Ingredient | Active Moiety | Effective |
|---|---|---|---|
| Calm | VALERIAN JWF5YAW3QW |
VALERIAN | 20260505 |
| Heartburn | VALERIAN JWF5YAW3QW |
VALERIAN | 20260505 |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| VALERIAN | 253206 | SU | MTHSPL |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Valerian used for in pharmaceutical contexts?
Valerian (CAS 8057-49-6) appears in DailyMed active-ingredient label rows, including Calm, Heartburn.
What are the known adverse events for Valerian?
Valerian has 134 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal discomfort, Abdominal distension, Abdominal pain, Acute kidney injury, Adverse food reaction. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Valerian also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Valeriana Officinalis Collina Root Extract with EU status "permitted".
What clinical phase is Valerian in?
No phase 1-4 clinical development badge is rendered for Valerian because the matched compound identifier rows do not contain a max-phase value.